{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:24:41Z","timestamp":1787030681669,"version":"build-2736575974"},"reference-count":32,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.7285","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T09:04:18Z","timestamp":1550480658000},"source":"Crossref","is-referenced-by-count":10,"title":["Effects of olanzapine on cytokine profile and brain-derived neurotrophic factor in drug-naive subjects with first-episode psychosis"],"prefix":"10.3892","author":[{"given":"Erifili","family":"Hatziagelaki","sequence":"first","affiliation":[{"name":"Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Centre, University General Hospital \u2018ATTIKON\u2019, School of Medicine, National and Kapodistrian University of Athens, 124 62 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Tsiavou","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Centre, University General Hospital \u2018ATTIKON\u2019, School of Medicine, National and Kapodistrian University of Athens, 124 62 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charilaos","family":"Gerasimou","sequence":"additional","affiliation":[{"name":"Second Department of Psychiatry, University General Hospital \u2018ATTIKON\u2019, School of Medicine, National and Kapodistrian University of Athens, 124 62 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Vavougios","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, University of Thessaly, School of Medicine, Biopolis, 41100 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aris","family":"Spathis","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Centre, University General Hospital \u2018ATTIKON\u2019, School of Medicine, National and Kapodistrian University of Athens, 124 62 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Laskos","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Microbiology, Athens Psychiatric Hospital \u2018Dromokaition\u2019, 124 61 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalabos","family":"Papageorgiou","sequence":"additional","affiliation":[{"name":"First Department of Psychiatry, Eginition Psychiatric Hospital, School of Medicine, National and Kapodistrian University of Athens, 115 28 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Douzenis","sequence":"additional","affiliation":[{"name":"Second Department of Psychiatry, University General Hospital \u2018ATTIKON\u2019, School of Medicine, National and Kapodistrian University of Athens, 124 62 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Christodoulou","sequence":"additional","affiliation":[{"name":"Department of Psychological Medicine, Nottinghamshire Healthcare NHS Trust, University of Nottingham Medical School, Nottingham NG7 2RD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaos","family":"Stefanis","sequence":"additional","affiliation":[{"name":"First Department of Psychiatry, Eginition Psychiatric Hospital, School of Medicine, National and Kapodistrian University of Athens, 115 28 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios","family":"Spandidos","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Virology, Medical School, University of Crete, 71003 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Nikolakakis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Faculty of Medicine, University of Crete, 71003 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Tsamakis","sequence":"additional","affiliation":[{"name":"Second Department of Psychiatry, University General Hospital \u2018ATTIKON\u2019, School of Medicine, National and Kapodistrian University of Athens, 124 62 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Rizos","sequence":"additional","affiliation":[{"name":"Second Department of Psychiatry, University General Hospital \u2018ATTIKON\u2019, School of Medicine, National and Kapodistrian University of Athens, 124 62 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,2,18]]},"reference":[{"key":"key20200713120515_b1-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","article-title":"Schizophrenia","volume":"374","author":"van Os","year":"2009","journal-title":"Lancet"},{"key":"key20200713120515_b2-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fnins.2013.00110","article-title":"Perinatal complications and schizophrenia: Involvement of the immune system","volume":"7","author":"Jenkins","year":"2013","journal-title":"Front Neurosci"},{"key":"key20200713120515_b3-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1176\/appi.ajp.2011.11030516","article-title":"Autoimmune diseases and severe infections as risk factors for schizophrenia: A 30-year population-based register study","volume":"168","author":"Benros","year":"2011","journal-title":"Am J Psychiatry"},{"key":"key20200713120515_b4-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.biopsych.2008.04.025","article-title":"Microglia activation in recent-onset schizophrenia: A quantitative (R)-[11C]PK11195 positron emission tomography study","volume":"64","author":"van Berckel","year":"2008","journal-title":"Biol Psychiatry"},{"key":"key20200713120515_b5-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2967\/jnumed.109.066647","article-title":"Neuroinflammation in schizophrenia-related psychosis: A PET study","volume":"50","author":"Doorduin","year":"2009","journal-title":"J Nucl Med"},{"key":"key20200713120515_b6-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol Psychiatry"},{"key":"key20200713120515_b7-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol Psychiatry"},{"key":"key20200713120515_b8-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Clinical antipsychotic trials of intervention effectiveness (CATIE) investigators: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"key20200713120515_b9-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.bbi.2006.02.002","article-title":"Cytokines in schizophrenia and the effects of antipsychotic drugs","volume":"20","author":"Drzyzga","year":"2006","journal-title":"Brain Behav Immun"},{"key":"key20200713120515_b10-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0022-3956(94)00049-W","article-title":"Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers","volume":"29","author":"Maes","year":"1995","journal-title":"J Psychiatr Res"},{"key":"key20200713120515_b11-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/BF02922260","article-title":"Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia","volume":"247","author":"M\u00fcller","year":"1997","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"key20200713120515_b12-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pharmthera.2011.06.003","article-title":"Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative\/cognitive symptoms and beyond","volume":"132","author":"Meyer","year":"2011","journal-title":"Pharmacol Ther"},{"key":"key20200713120515_b13-etm-0-0-7285","article-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"key20200713120515_b14-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"key20200713120515_b15-etm-0-0-7285","first-page":"77","article-title":"Positive and Negative Syndrome Scale (PANSS) training: Challenges, solutions, and future directions","volume":"14","author":"Opler","year":"2017","journal-title":"Innov Clin Neurosci"},{"key":"key20200713120515_b16-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/PL00014187","article-title":"The role of immune function in schizophrenia: An overview","volume":"249","author":"M\u00fcller","year":"1999","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"key20200713120515_b17-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1017\/S1461145710001653","article-title":"An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces","volume":"14","author":"Drexhage","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"key20200713120515_b18-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","article-title":"Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis","volume":"155","author":"Upthegrove","year":"2014","journal-title":"Schizophr Res"},{"key":"key20200713120515_b19-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: Implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"key20200713120515_b20-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.schres.2013.03.027","article-title":"Antipsychotics can modulate the cytokine profile in schizophrenia: Attenuation of the type-2 inflammatory response","volume":"147","author":"Borovcanin","year":"2013","journal-title":"Schizophr Res"},{"key":"key20200713120515_b21-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/ar2680","article-title":"The biological and clinical importance of the \u2018new generation\u2019 cytokines in rheumatic diseases","volume":"11","author":"Gabay","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"key20200713120515_b22-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1189\/jlb.0609445","article-title":"Interleukin 27: A double-edged sword for offense and defense","volume":"86","author":"Yoshida","year":"2009","journal-title":"J Leukoc Biol"},{"key":"key20200713120515_b23-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1155\/2010\/832454","article-title":"Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23 and IL-27","volume":"2010","author":"Xu","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"key20200713120515_b24-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells","volume":"16","author":"Pflanz","year":"2002","journal-title":"Immunity"},{"key":"key20200713120515_b25-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2174\/157339510791823673","article-title":"Immune system and schizophrenia","volume":"6","author":"M\u00fcller","year":"2010","journal-title":"Curr Immunol Rev"},{"key":"key20200713120515_b26-etm-0-0-7285","first-page":"21","article-title":"Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients","volume":"22","author":"Hori","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"key20200713120515_b27-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.intimp.2005.10.004","article-title":"Antipsychotic treatment may alter T-helper (TH)2 arm cytokines","volume":"6","author":"Pae","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"key20200713120515_b28-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0920-9964(01)00296-1","article-title":"Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: Association with psychopathology","volume":"57","author":"Zhang","year":"2002","journal-title":"Schizophr Res"},{"key":"key20200713120515_b29-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/0896-6273(90)90089-X","article-title":"NT-3, BDNF, and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression","volume":"5","author":"Maisonpierre","year":"1990","journal-title":"Neuron"},{"key":"key20200713120515_b30-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"e42676","DOI":"10.1371\/journal.pone.0042676","article-title":"Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder","volume":"7","author":"Yoshida","year":"2012","journal-title":"PLoS One"},{"key":"key20200713120515_b31-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/15622970802182733","article-title":"Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics","volume":"11","author":"Rizos","year":"2010","journal-title":"World J Biol Psychiatry"},{"key":"key20200713120515_b32-etm-0-0-7285","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000315438","article-title":"Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia","volume":"62","author":"Rizos","year":"2010","journal-title":"Neuropsychobiology"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T07:33:15Z","timestamp":1594625595000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.7285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,18]]},"references-count":32,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.7285","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,18]]}}}